Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

ICU Medical Inc
NASDAQ:ICUI

Watchlist Manager
ICU Medical Inc Logo
ICU Medical Inc
NASDAQ:ICUI
Watchlist
Price: 152.01 USD -1.39% Market Closed
Market Cap: $3.8B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

Assets
+
3Y
-8%
5Y
+137%
10Y
+572%
Liabilities
+
3Y
-19%
5Y
+612%
10Y
+4 484%
Equity
+
3Y
+6%
5Y
+46%
10Y
+275%

Balance Sheet Decomposition
ICU Medical Inc

Balance Sheet
ICU Medical Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
4
4
2
6
7
13
8
56
51
79
100
147
226
276
336
445
290
345
269
396
553
209
254
309
Cash Equivalents
4
4
2
6
7
13
8
56
51
79
100
147
226
276
336
445
290
345
269
396
553
209
254
309
Short-Term Investments
69
84
71
82
80
104
88
56
57
15
60
79
71
71
41
0
10
37
24
15
14
4
1
0
Total Receivables
13
17
31
18
29
31
29
43
50
53
49
51
51
43
72
68
230
213
222
128
110
225
164
187
Accounts Receivables
13
17
25
9
24
27
26
38
48
51
44
49
45
39
58
56
113
176
202
124
106
222
162
183
Other Receivables
0
0
6
9
5
5
3
5
2
2
6
2
6
4
14
12
118
37
20
4
4
4
3
4
Inventory
2
6
3
8
15
16
20
18
41
44
40
36
35
37
44
49
289
311
338
315
290
696
709
585
Other Current Assets
3
3
4
3
7
7
9
7
9
15
11
12
12
11
12
6
46
21
30
67
62
101
93
361
Total Current Assets
90
114
111
117
138
171
153
179
208
205
260
326
394
437
505
569
865
927
882
921
1 030
1 235
1 221
1 442
PP&E Net
25
35
41
41
52
59
73
70
77
84
83
86
88
86
74
86
399
433
491
513
508
714
686
499
PP&E Gross
25
35
41
41
52
59
73
70
77
84
83
86
88
86
74
86
399
433
491
513
508
714
686
499
Accumulated Depreciation
20
24
31
33
39
43
51
61
73
86
100
113
125
139
149
158
210
262
320
377
437
526
624
593
Intangible Assets
0
3
4
3
11
10
12
11
17
15
11
10
9
7
24
22
144
133
211
197
188
983
871
741
Goodwill
0
0
0
0
0
0
0
0
2
2
2
2
2
2
7
6
12
11
31
33
43
1 449
1 472
1 433
Note Receivable
0
0
5
4
2
0
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
11
0
0
0
0
0
0
0
0
15
2
0
13
5
4
3
3
Other Long-Term Assets
2
5
3
0
1
4
3
11
5
5
5
6
8
9
17
22
63
79
77
87
106
131
125
86
Other Assets
0
0
0
0
0
0
0
0
2
2
2
2
2
2
7
6
12
11
31
33
43
1 449
1 472
1 433
Total Assets
117
N/A
157
+34%
164
+5%
165
+0%
205
+24%
244
+19%
243
-1%
283
+17%
309
+9%
310
+0%
361
+17%
429
+19%
500
+17%
541
+8%
627
+16%
705
+12%
1 497
+112%
1 585
+6%
1 692
+7%
1 764
+4%
1 881
+7%
4 516
+140%
4 378
-3%
4 204
-4%
Liabilities
Accounts Payable
2
5
3
3
5
8
8
8
18
11
13
11
11
11
14
15
78
121
129
72
81
216
150
148
Accrued Liabilities
6
5
5
5
9
8
13
14
13
15
16
18
16
17
29
26
129
125
111
91
105
211
236
275
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
31
52
52
Other Current Liabilities
2
2
0
0
0
0
0
0
2
0
0
0
0
0
0
0
3
4
9
32
14
37
44
81
Total Current Liabilities
11
12
8
8
14
16
22
22
34
26
29
29
27
29
43
41
210
249
249
196
201
495
482
556
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
1 626
1 580
1 534
Deferred Income Tax
0
0
0
0
1
3
4
4
6
8
7
5
4
1
1
1
2
1
2
2
2
126
56
49
Minority Interest
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
3
4
5
4
4
3
4
3
3
3
87
72
65
62
60
180
138
100
Total Liabilities
11
N/A
12
+8%
8
-28%
8
+1%
15
+82%
19
+27%
29
+48%
30
+6%
44
+45%
38
-14%
41
+7%
38
-7%
35
-7%
33
-6%
47
+43%
45
-5%
299
+571%
322
+8%
315
-2%
261
-17%
265
+1%
2 426
+816%
2 255
-7%
2 239
-1%
Equity
Common Stock
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Retained Earnings
61
81
103
108
128
154
177
201
228
256
301
342
383
409
454
517
586
621
722
809
912
838
808
690
Additional Paid In Capital
46
63
64
62
60
75
75
51
54
57
57
64
79
107
145
163
626
658
669
693
721
1 331
1 366
1 412
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
3
0
41
22
6
Treasury Stock
1
0
12
15
1
5
41
2
20
41
35
15
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
1
0
0
1
1
1
1
3
1
2
10
21
21
15
17
17
4
19
122
75
145
Total Equity
107
N/A
145
+36%
156
+7%
156
+0%
189
+21%
225
+19%
214
-5%
253
+18%
265
+5%
272
+3%
321
+18%
391
+22%
465
+19%
508
+9%
580
+14%
660
+14%
1 198
+82%
1 264
+5%
1 377
+9%
1 502
+9%
1 616
+8%
2 090
+29%
2 123
+2%
1 965
-7%
Total Liabilities & Equity
117
N/A
157
+34%
164
+5%
165
+0%
205
+24%
244
+19%
243
-1%
283
+17%
309
+9%
310
+0%
361
+17%
429
+19%
500
+17%
541
+8%
627
+16%
705
+12%
1 497
+112%
1 585
+6%
1 692
+7%
1 764
+4%
1 881
+7%
4 516
+140%
4 378
-3%
4 204
-4%
Shares Outstanding
Common Shares Outstanding
13
14
14
14
14
15
14
15
14
14
14
15
15
16
16
16
20
21
21
21
21
24
24
25

See Also

Summary
ICUI intrinsic value, competitors valuation, and company profile.
DCF Valuation
ICUI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ICUI stock valuation using valuation multiples.
Wall Street Estimates
ICUI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ICUI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 316,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.